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esponsibility of InstAbstract The aim of this study was to formulate drug-loaded bio-lipstrips using novel bioexcipients
isolated from the fruit pulp of Litchi chinesis (biomaterial L) and to explore the potentiality of lip skin as a
novel translabial drug delivery system. The biomaterial, prepared by a simpliﬁed economical process and
puriﬁed by hot dialysis, was subjected to various physicochemical evaluations along with spectral analysis
including UV, FT-IR, Mass and 1H NMR. The lipstrip formulated with the novel bioexcipients was
screened for its functional properties, including ﬁlmability using a ﬁlm-casting method, and bio/muco-
adhesitivity using a shear-stress method, the Park and Robinson method and a rotating cylinder method.
Rosiglitazone-loaded bio-lipstrips were formulated by using biomaterial L as a strip former and dextrose
as a ﬂexicizer. The formulated strips were subjected to various evaluations, including thickness, folding
endurance, in-vitro release and in-vivo release. The release of rosiglitazone maleate was maintained over
24 h, which was conﬁrmed in in-vitro and in-vivo release experiments. Our results reveal that this
biopolymer possesses promising stripability as well as bio-adhesitivity. The formulated bio-lipstrips are
feasible for delivering rosiglitazone maleate by translabial administration.
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The skin of lips is unique. It lacks infrastructure, making it pliable.
It consists primarily of mucous membrane, which has fewer and
different glands than ordinary skin. The lip is also unlike other
skin in that the outer layer (stratum corneum) is extremely thin or
completely absent in most people. Lips also have almost no
melanin, the natural pigment in skin that helps screen out the sun's
harmful rays. The translabial application of drugs provides several
beneﬁts, including the avoidance of hepatic ﬁrst-pass metabolism
and the ability to provide nearly constant drug delivery over a long
period, which may reduce systemic adverse effects1–4. The skin
forms an excellent barrier against drug permeation due to the rigid
lamellar structure of the stratum corneum lipids. Our novel
translabial drug delivery sidesteps this barrier due to very thin or
absent layers of stratum corneum.
Rosiglitazone maleate belongs to the drug class of thiazolidi-
nediones. It is a selective agonist for peroxisome proliferator-
activated receptor gamma (PPARγ)5 and particularly suitable for
diabetic patients who are overweight and for whom metformin is
contraindicated6,7. Rosiglitazone reduces fasting and postprandial
glucose levels and effectively lowers plasma insulin and triglycer-
ide levels8. It regulates the transcription of certain insulin-
responsive genes and subsequently improves insulin sensitivity
and controls glucose production, transport and utilization9. The
drug has a log P value of 2.1, which contributes to its lipid
solubility and hydrophilicity. However, rosiglitazone is metabo-
lized extensively by N-demethylation and hydroxylation, followed
by conjugation with sulfate and glucuronic acid in the liver with an
elimination half-life of 3–5 h10, necessitating frequent administra-
tion. Recently, a study has indicated that sustained delivery of
rosiglitazone through a transdermal route can help avoid toxicity
due to a sudden high blood concentration. This study was
undertaken to screen the potential of rosiglitazone maleate for
transdermal delivery.
Natural polysaccharides from biomaterials have been widely
used as bioadhesive materials because of their biocompatibility
and biodegradability. The Litchi chinesis biomaterial (biomaterial
L) used in this study was isolated from the pulp of a subtropical
evergreen tree Lichi chinesis, which belongs to the family of
Sapindaceae. The pulp of lichi contains carbohydrate, dietary ﬁber,
fat, protein, vitamin C and minerals11. Litchi chinensis has been
reported to have anti-inﬂammatory, antioxidant antidiabetic, anti-
platelet and anticoagulant activities12. In our research work,
biomaterial L was used as a bioadhesive and strip-forming agent
in the dosage form.
The aim of our research was to isolate biomaterial L, formulate
lipstrips using this material, evaluate its bioadhesitivity and strip-
forming capability, and determine the suitability of bio-lipstrips as
a drug delivery method for rosiglitazone maleate.2. Materials and methods
2.1. Materials
Rosiglitazone maleate (assigned purity, 99.8%) was a gift from
Sun Pharma (Mumbai, India). Ripened fruits of Litchi chinesis
were purchased from the market of Dehradun, Uttarakhand, India.
Sodium carboxy methylcellulose (CMC-Na) and HPMC were
purchased from Merck Specialties Private Limited. (Mumbai,
India). All other chemicals and solvents were of analytical grade.2.2. Isolation of biomaterial L
Litchi chinesis fruits (ripened) were collected from the local
market and the pulps were separated from the fruits. Litchi
chinesis pulps (100 g) were treated with 500 mL of doubly-
distilled water and stirred with a mechanical stirrer at 4000 rpm
for 1 h. The mixture was subjected to centrifugation at 4000 rpm
for 30 min. The supernatant was treated with a triple volume of
acetone and the mixture was refrigerated for 12 h, after which
the mixture was centrifuged at 5000 rpm for 30 min. The
supernatant was discarded and the insoluble material was dried
in a vacuum desiccator for 14 h. The dried biomaterial was
puriﬁed by the hot dialysis method using an ORCHID scientiﬁc
dialysis apparatus for complete removal of impurities like
chlorides and sulfates. The procedure was optimized by repeat-
ing the procedure 6 times and the percentage yield was
calculated. The puriﬁed biomaterial L was screened through
200# mesh and stored for later use.
2.3. Preparation of bioadhesive lipstrips
Biopolymer L (100 mg) was placed in a mortar and 110 mg of
dextrose was added. Both were triturated for 5 min, after which
5 mg of rosiglitazone maleate was incorporated in a geometrical
dilution pattern. Doubly-distilled water (10 mL) was added drop-
wise with constant trituration. The mixture was subjected to
magnetic stirring for 10 min and sonicated at 400 Hz for 3 cycles
of 60 s each in order to obtain a colloidal mixture. The colloidal
mixture was poured into a culture dish with a diameter of 6 cm and
was evaporated at room temperature for 10 h, allowing a dried
layer to form. The layer was carefully removed and cut into
2 cm 2 cm squares. Ethyl cellulose was used as a backing
membrane. A similar procedure was adopted for other concentra-
tions of biopolymer L, CMC-Na and sodium alginate polymers
(Table 1).
2.4. Characterization of biomaterial L
The isolated biomaterial L was subjected to physicochemical
analysis, including solubility, color changing point, color, texture,
protein and carbohydrate content, SEM analysis and FT-IR, mass
spectrometry and 1H NMR spectroscopy studies.
It was further evaluated for its adhesitivity by using a shear
stress method, the Park and Robinson method and a rotating
cylinder method. The results were compared with the commonly
used adhesive materials, CMC-Na and HPMC.
2.4.1. In-vitro adhesive study using the shear stress method
The mucoadhesive properties of biomaterial L was determined
in vitro by the shear stress method. Three different concentrations
of biomaterial L (1%, 3% and 5% w/v) were placed between two
glass plates and subjected to a shear stress for assessment for in-
vitro adhesive strength in terms of weight required for breaking
adhesive bonds between the material and the glass plate after a
speciﬁed contact time of 5, 10, 15 and 30 min. The results were
compared with polymer CMC-Na (1%)13.
2.4.2. Ex-vivo mucoadhesive studies
2.4.2.1. Park and Robinson method. Goat intestine membrane
was used to assess the mucoadhesivity of biomaterial L by Park
and Robinson method. The biomaterial L was compressed into a
Table 1 Formulation of various bio-lipstrips.
Serial no. Ingredient SA1 SA2 LA1 LA2 LA3 LA4 LA5 LA6
1 Rosiglitazone maleate (mg) 5 5 5 5 5 5 5 5
2 Litchi chinesis (L.) biopolymer (mg) – – 100 (1%) 200 (2%) 300 (3%) 400 (4%) 500 (5%) 600 (6%)
3 Sodium carboxy methyl cellulose (mg) 400 (4%) – – – – – – –
4 Sodium alginate (mg) – 400 (4%) – – – – – –
5 Dextrose (mg) 110 110 110 110 110 110 110 110
6 Double distilled water (mL) 10 10 10 10 10 10 10 10
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terial L were lightly pressed for 10 min between the mucosal
surfaces of goat intestine which was tied to the mouth of a glass
vessel and a cap connected with a weight measurement device.
The detachment force required to separate the disc from mucosal
surface was measured in triplicate and the results were compared
with the commonly used polymers like CMC-Na and HPMC14.
2.4.2.2. Rotating cylinder method. The length of adhesion of
biomaterial L compressed on a disc to goat intestinal membrane
was evaluated by the rotating cylinder method using a USP Type-
II dissolution apparatus. The freshly prepared intestinal membrane
was attached to the cylindrical basket. The compressed disc was
carefully adhered to the membrane by prior wetting with water.
The cylinders were positioned in the basket containing 900 mL of
phosphate buffer at pH 7.4 at 3772 1C. The study was conducted
at a speed of 100 rpm. The disc was observed at different time
intervals. The time required for dislodgment and/or disintegration
of disc was recorded and the study was conducted in triplicates.
The results were compared with the commonly used polymers like
CMC-Na and HPMC15.
2.5. Drug–excipient interaction study
The pure drug along with formulation excipients was subjected to
interaction studies.
2.5.1. UV spectroscopy
The study was carried out by dry and wet mixing of drug and
excipients in the ratios of 1:1, 1:3 and 3:1. Both types of mixtures
were stored at room temperature and at 55 1C for three days. The
appropriate dilutions were done with methanol and pH 7.4
phosphate buffer and the samples were scanned at λmax using
UV spectroscopy.
2.5.2. FT-IR spectroscopy
The study was performed using FT-IR spectroscopy by mixing or
ﬁnely grinding various proportions of drug and excipients with a
specially puriﬁed salt (potassium bromide) to remove scattering
effects from large crystals. The powder mixture was then pressed
in a mechanical press to form a translucent pellet through which
the beam of the spectrometer could pass.
2.6. Characterization of drug-loaded bio-lipstrips
2.6.1. Thickness
The thickness of three randomly selected bio-lipstrips was assessed
at ﬁve different places (the center and four corners) on a singlepatch of each formulation using a micrometer screw gauge and the
mean values were calculated16.
2.6.2. Weight uniformity study
Three bio-lipstrips with the surface area of 1 cm2 were randomly
selected from each formulation. Each strip was weighed and the
study was performed in triplicate and average weights were
calculated16,17.
2.6.3. Content uniformity
Formulated drug-loaded bio-lipstrips were evaluated for unifor-
mity of drug content. Strips of 1 cm2 from each formulation were
randomly selected and transferred into a 100 mL volumetric ﬂask
containing 7 mL pH 7.4 phosphate buffer and 1 mL methanol. The
ﬂask was stirred for 4 h on magnetic stirrer. A blank control was
similarly prepared using a drug-free strip. The obtained solutions
were ﬁltered through a 0.45 μm membrane. The drug content was
then determined after proper dilution by UV spectrophotometry
(Shimadzu 1800)16,17.
2.6.4. Folding endurance
Folding endurance for all bio-lipstrips containing rosiglitazone was
performed by using a strip with area of 4 cm2 from each
formulation. The selected bio-lipstrips were subjected to folding
endurance by repeatedly folding strips at the same place until
broken. The number of foldings required to break or crack a strip
was recorded as the folding endurance18,19. The measurement was
repeated in triplicate.
2.6.5. Swelling index
Drug-loaded bio-strips with a size of 1 cm2 from each formulation
were selected for the swelling study. Each bio-lipstrip was
weighed on a cover slip and placed in a culture dish and 10 mL
of phosphate buffer of pH 7.4 was added. After one hour the cover
slip with bio-lipstrip was weighed. The difference in the weights
gives the weight increase due to absorption of water and swelling
of bio-ﬁlm. The procedure was repeated in triplicate and the
swelling index (S) was determined by Eq. (1).
Sð%Þ ¼ ðXt–X0=X0Þ  100% ð1Þ
where Xt is the weight of the swollen bio-strip after time t and X0 is
the original weight of bio-strip20.
2.6.6. Percentage moisture absorption (PMA)
A percent moisture absorption study for all formulated bio-lipstrips
was conducted with 1 cm2 of rosiglitazone-loaded bio-lipstrips.
The bio-lipstrips were transferred into a watch glass and placed in
a dessicator containing a saturated solution of aluminum chloride
Figure 1 IR spectrum of isolated biomaterial L.
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study was repeated thrice and the percentage moisture absorption
calculated by using the following formula21:
Moisture absorption ð%Þ
¼ ½ðfinal weight initial weightÞ=initial weight  100% ð2Þ
2.6.7. Percentage moisture loss (PML)
A percentage moisture loss study for all formulated bio-lipstrips
was performed by taking three 1 cm2 strips from each formulation.
The strips were cut out and weighed and kept in desiccator
containing fused anhydrous calcium chloride for 72 h. At the end,
the weight loss by the strips was determined. The study was
repeated thrice and percentage moisture loss calculated by using
the following formula (3),21:
Moisture loss ð%Þ
¼ ½ðinitial weight final weightÞ=initial weight  100% ð3Þ
2.6.8. Surface pH study
The surface pH of the bio-lipstrips containing rosiglitazone was
determined by using a glass electrode. The bio-lipstrips were
allowed to swell by keeping them in contact with 0.5 mL of
distilled water for 1 h at room temperature. The pH was measured
by bringing the electrode in contact with the surface of the bio-
strip and allowing it to equilibrate for 1 min. The experiments were
performed in triplicate and average values were noted22.
2.6.9. Water vapor transmission test (WVT)
WVT is deﬁned as the quantity of moisture transmitted through a unit
area of strip in unit time. A glass bottle (length of 5 cm, narrow mouth
with internal diameter of 0.8 cm) ﬁlled with 2 g anhydrous calcium
chloride and an adhesive (Feviquicks) spread across its rim was used
in the study. The bio-strip was ﬁxed over the adhesive and the
assembly was placed in a sealed desiccator containing 200 mL of
saturated sodium bromide and saturated potassium chloride solution.
The weighed bottle was then placed in a desiccator and the procedure
was repeated23,24.
WVT¼W=ST ð4Þ
where W is the increase in weight in 24 h; S is area of strip
exposed (cm2); T is exposure time.
2.6.10. Skin irritancy
Primary skin irritation studies were conducted for the two best-
optimized patches on four rabbits. Rabbits were divided into two
groups of two animals. A blank strip was applied on the lip of rabbits
of group I, which served as control, and rabbits of group II received
medicated strips on their lip. Strips were replaced after 6 h with fresh
strips. The study was carried out for a period of 7 days and application
sites were visually graded for redness, erythematosis or irritation25.
2.6.11. In-vitro diffusion study
The in-vitro drug diffusion assay was carried out in the M.S. diffusion
apparatus. This was the static method and employed complete
replacement of the sample. Dialysis membrane was tied to the terminal
portion of the cylindrical donor compartment. A 1 cm2 bio-lipstrip was
kept above the dialysis membrane in the donor compartment, and
the receiver compartment was ﬁlled with 13 mL of diffusion medium.
The complete sample was withdrawn at different time intervals and the
receiver compartment was reﬁlled with 13 mL of fresh medium. Theamount of drug released was assessed by measuring the absorbance at
247 nm using a UV spectrophotometer (Shimadzu 1800).
2.6.12. In-vivo release study
The in-vivo release was performed in rabbits for the optimized
formulation. The bio-lipstrip was applied to the lip of rabbit and
blood samples were taken from the ear vein at intervals of 2, 6, 10, 12
and 24 h to determine the concentration of drug in the blood plasma.
Plasma was separated immediately by centrifugation at 3000 g for
10 min. The plasma was treated with 5 mL HPLC-grade methanol,
subjected to sonication for 5 cycles, and ﬁltered through a membrane
ﬁlter. The drug content was estimated by injecting the ﬁltrate into the
HPLC column using methanol and phosphate buffer of pH 7.4 as
mobile phase and at a rate of 1.2 mL/min22.
2.6.13. Stability studies
Optimized bio-lipstrip was subjected to a stability study. Bio-strips
were wrapped in aluminum foil and packed in glass vials. These strips
were kept in an incubator maintained at 3775 1C and 7575% R.H.
for 6 months. The changes in appearance, physical characteristics and
release behavior of the stored strips were investigated after 1–6 months.
The data presented are the mean of three determinants23.3. Results and discussion
3.1. Spectral analysis of the biomaterial L
The isolated biomaterial L was smooth, amorphous, yellowish white
and slightly soluble in water. The yield was found to be 1.8570.05%
w/w. The biomaterial L showed a positive test for Fehling's solution
and a positive ninhydrin test, which revealed the presence of
carbohydrate and protein, respectively. The color changing point and
λmax for biomaterial L was found to be 255 1C and 290 nm,
respectively. The IR spectra revealed the presence of secondary alcohol
(1099.83 cm1), aromatic nitro and phenol groups (1316.59 cm1),
aromatic rings (1544.70 cm1), and the presence of alkenes
(1652.02 cm1), with –CH2 and –COOH stretching (2928.35 cm
1)
along with β-diketones and O–NO2 (1652.02 cm
1) (Fig. 1). These
functional groups, such as ketonic and nitro groups, are likely
responsible for the mucoadhesive activity of the bio-polymer as these
groups are observed in mucoadhesive polymers like HPMC and
polycarbophil. The NMR spectra showed δ values 1.2, 2.3 and 6.4,
which revealed the presence of hydroxyl, esters and aromatic groups,
N.V. Satheesh Madhav, A.P. Yadav412respectively (Fig. 2). The mass spectrum shows a large molecular
weight structure likely polymeric, and the presence of proteins. It
showed a parent peak at m/z 345.1 (Fig. 3).Figure 2 1H NMR spectrum of isolated biomaterial L.
Figure 3 Mass spectrum o
Figure 4 SEM of isolated biomateri3.2. SEM of biomaterial L
The topography of the biomaterial L revealed that it has rough, ﬂaky
structure with additional granular structure on the ﬂaky surface. This
clearly indicates it is slightly granular and polymeric in nature (Fig. 4).
3.3. Adhesitivity of biopolymer L
The study of adhesitivity (Figs. 5, 6 and 7) showed that the
biomaterial L has signiﬁcant adhesitivity in comparison with
CMC-Na and HPMC. The result of adhesitivity test revealed that
the isolated biomaterial L from the pulp of Litchi chinesis
possesses notable muco/bio-adhesitivity.
3.4. Drug–excipient interaction study
The drug interaction study revealed that there was no interaction
between the drug and the excipients, including the biomaterial L,
because there was no change in the λmax value, which was
observed at 247 nm prior to and after the test.
All the FT-IR peaks of rosiglitazone maleate were present as
such in the spectra of ground drug and excipient mixture. No
observable signs of drug interaction were observed. We conclude
that the excipients had no detrimental effect on the drug and could
be used safely for the formulation of the bio-ﬁlms.f isolated biomaterial L.
al L. (A) 1500 and (B) 600 .
Figure 6 Ex-vivo mucoadhesivity evaluated by rotating cylinder method.
L: Biomaterial L.
Figure 7 Ex-vivo mucoadhesivity evaluated by Park and Robinson
method. L: Biomaterial L.
Figure 5 In-vitro mucoadhesivity evaluated by shear stress method. L:
Biomaterial L.
Utilizing bioexcipients for the translabial delivery of rosiglitazone maleate 4133.5. Thickness, swelling index, surface pH and folding
endurance
The average thickness of all prepared bio-lipstrips ranged
0.3670.03 to 0.4670.07 mm. Weight variation values of all
strips (1 cm2) were found in the range 28.7570.23 to39.9370.37 mg. Thus, the proportional gain in the weight of
strips was observed as the thickness of the strips increased. The
values were uniform for the strips within each formulation type,
indicating that the strip casting was uniform.
The range of the swelling index for the bio-strips was found to
be 101.3370.54 to 153.7570.61. The swelling index suggests
that they will cause minimal discomfort when in use. This property
of the strip has a direct inﬂuence on release of drug.
The surface pH for all formulations was found to range from
6.3270.31 to 6.5270.43. Since the pH range of the strip was
close to the skin pH, no skin irritation was expected.
The folding endurance of strips fell in the range 11970.56 to
19470.48. High folding endurance values for strips indicates high
mechanical strength of strips. This is highly desirable because it
would prevent dislocation of the strips from the site of application
or breaking of the strip during administration.3.6. Skin irritation, moisture content, moisture uptake, WVT and
content uniformity
No skin irritation, redness or erythema was observed during the
primary skin irritation studies with all formulations.
The moisture content of the prepared formulation was low,
which could help the formulation remain stable and reduce
brittleness during long term storage. The moisture content of the
bio-strips ranged from 0.9270.08% to 1.3870.15%.
Moisture uptake for the bio-strips ranged from 3.2870.21% to
4.9670.39%. The moisture uptake of the formulation was low,
which protects the formulation from microbial contamination and
reduces bulkiness.
The range of WVT for the bio-strips was found to be
4.8170.41 to 7.4070.53.
The range of content uniformity for the bio-strips was found to
be between 91.5870.81% to 96.470.74%. There was no
signiﬁcant difference in the drug content among the all bio-
lipstrips, which indicated uniform dispersion of drug throughout
the strips.3.7. In-vitro release
The in-vitro release of rosiglitazone from the different strips is
shown in Fig. 8. All the formulations released 490% of the drug
within 10 h. Formulation LA2 showed the maximum release of
99.81% at the end of 24 h. Formulation LA4 showed the slowest
drug release, and showed maximum drug release of 96.98% after
24 h. We could not detect any relationship between the drug
release proﬁle and the polymer composition. We can only infer
that the release mechanism might include diffusion as well as
erosion, since our biomaterial is slightly soluble in water. The
release data of the tested strips was analyzed on the basis of the
Krosmeyer–Peppas equation and Higuchi kinetics (by BIT-SOFT
1.12: drug release kinetics with model ﬁtting). Coefﬁcients of
correlation (R2) were used to evaluate the accuracy of ﬁt. The R2
values for the Higuchi and Peppas kinetic models were calculated
and compared. All the tested formulations gave good ﬁt to the
Krosmeyer–Peppas model. All formulations showed non-Fickian
drug release (0.5ono1). On the basis of the above determina-
tions, LA3 was selected as the best formulation.
Figure 9 In-vivo release of rosiglitazone from translibially adminis-
tered bio-lipstrips in rabbit plasma.
Figure 8 In-vitro release of rosiglitazone from bio-lipstrips with
different concentration of biomaterial L (1–6%) compared with strips
with CMC-Na (4%) and sodium alginate (4%).
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At the end of stability study, the tested strips showed little to no
drug loss. They also showed an insigniﬁcant difference for in-vitro
drug release. All optimized strips showed satisfactory ﬂexibility
and elastic properties during and at the end of the accelerated
stability period. These indicate that there were no inﬂuences on the
chemical and physical stability of the formulation during the test
period.3.9. In vivo study
Translabial administration of LA3 bio-lipstrip achieved a Cmax of
rosiglitazone of 23.084 ng/mL at a Tmax of 12 h. The AUC0–24 h
was found to be 336.55 ng·h/mL (Fig. 9). The results indicated that
rosiglitazone can enter the blood circulation via labial route,proving that it can be an option when consider transdermal
delivery.4. Conclusions
In the present study, bioadhesive bio-lipstrips based on Lichi
chinesis biomaterial were developed and shown to release drug
over the required period of time (12 h). Thus, a stable bioadhesive
bio-lipstrip of rosiglitazone for the treatment of diabetes using this
novel biomaterial was demonstrated. The biomaterial showed good
strip-forming ability as well as satisfactory bioadhesion. Thus, this
natural biomaterial could be a promising excipient for the systemic
delivery of drugs through a labial route or other transdermal
routes.
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